N Anthony Coles's Net Worth

N Anthony Coles's net worth is estimated to be at least $33,390,762.59 as of 11/23/2024. CoreStreet's estimation of N Anthony Coles's net worth is based on their sale of stock and current holding of stock.

N Anthony Coles is Director at Cerevel Therapeutics Holdings Inc. They have executed at least 20 trades of stock as per SEC Form 4 filings. Their most recent trade was for 25,000 units of CERE stock on 07/01/2024. Their biggest sale was on 09/15/2021 when they sold 11,948 units of Regeneron Pharmaceuticals Inc stock for $7,873,493.04. They typically trade 3 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $33,390,762.59
Most recent insider trade:
  • July 1, 2024

N Anthony Coles's Insider Trading History

Cerevel Therapeutics Holdings IncTitleAmountPriceTypeTotal Value
July 1, 2024
Director25,000$41.18Sell$1,029,500.00
May 10, 2024
Director50,000$42.10Sell$2,105,000.00
March 4, 2024
Director50,000$41.01Sell$2,050,500.00
Feb. 29, 2024
Director50,000$41.16Sell$2,058,000.00
Feb. 7, 2024
Director2,506$41.54Sell$104,099.24
Nov. 8, 2023
Director100$25.16Sell$2,516.00
Nov. 3, 2023
Director61,401$25.43Sell$1,561,427.43
Sept. 7, 2023
Director50,000$24.07Sell$1,203,500.00
July 11, 2023
Director50,000$30.03Sell$1,501,500.00
June 1, 2023
CEO50,000$32.60Sell$1,630,000.00
May 4, 2023
CEO50,000$31.47Sell$1,573,500.00
April 11, 2023
CEO50,000$25.06Sell$1,253,000.00
March 3, 2023
CEO3,000$27.19Sell$81,570.00
Feb. 7, 2023
CEO50,000$33.13Sell$1,656,500.00
Jan. 5, 2023
CEO50,000$29.94Sell$1,497,000.00
Dec. 9, 2022
CEO50,000$26.67Sell$1,333,500.00
Regeneron Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Dec. 28, 2022
Director5,758$714.11Sell$4,111,845.38
Sept. 15, 2021
Director11,948$658.98Sell$7,873,493.04
McKesson CorporationTitleAmountPriceTypeTotal Value
Aug. 31, 2018
Director1,350$128.69Sell$173,731.50
Amgen IncTitleAmountPriceTypeTotal Value
June 5, 2013
CEO6,562$90.00Sell$590,580.00